Getting ready for the WEEI Dana-Farber telethon to raise money for cancer research! #KCANCER

1/ 🚨 Just in European Urology , our study on first-line systemic therapy following adjuvant immunotherapy in renal cell carcinoma. Effort co-led with Talal El Zarif, MD, with amazing mentorship from Daniel Heng Toni Choueiri, MD sciencedirect.com/science/articl… Dana-Farber Lank Center for Genitourinary Oncology Yale School of Medicine OncoAlert

⁦Yale IM Traditional Residency Program⁩ Red Block Retreat today at Nuzzo’s Farm! ⁦Yale Internal Medicine⁩

I am excited to begin with my FY23 CDMRP KCRP Fellowship Award. Would appreciate my mentor David Braun for having me this amazing opportunity and wonderful projects. I thrilled to attack underlying resistant mechanisms in the aRCC. Sokuになってるけど😅↓ x.gd/jY8Lr

Our study on sex differences in Xp11 translocation renal cell carcinoma is out Cell! We ascribe a genetic basis to the female bias in tRCC, which is driven by a translocation of the TFE3 gene on the X chromosome. w Zhang lab @danafarbernews bit.ly/4dtpNtP 🧵1/

We are hiring a postdoc .. Apply through link below Postdoctoral Fellow PhD- Microbiome and Immuno-oncology nature.com/naturecareers/…

#ICYMI... Yale #researchers, including David Braun, analyzed clinical data from 734 patients who had the same diagnosis of clear cell #kidneycancer, received the same therapy yet had different outcomes. Learn more➡️tinyurl.com/ym7dyzjr Yale Cancer Center|Smilow Cancer Hospital|Yale School of Medicine

1/ Results from #LITESPARK-005 are out NEJM! The phase 3 trial that led to HIF-2 inhibitor Belzutifan (BEL) U.S. FDA approval Dec 2023 in pretreated pts w/ #ccRCC. Presentation #ESMO24 @myEsmo Check it out: nejm.org/doi/full/10.10…

🎙️ #ICYMI: We sat down with Bradley McGregor to discuss his journey from early influences and mentors to his current role at Dana-Farber. 📺 Watch Here: buff.ly/3Ma6h9W

Congratulations Jeffrey Ishizuka, MD, DPhil, Jeffrey Ishizuka recipient of an #R61 award from the National Cancer Institute for development of novel cell reporting tools to study tumor inflammation. Smilow Cancer Hospital Yale School of Medicine Yale New Haven Hosp Yale Department of Immunobiology

Time to next therapy was strongly associated with OS in patients with metastatic RCC previously treated with ICI-based therapy, prompting further investigation into this potentially meaningful intermediate trial end point. Renee Maria Saliby Dana-Farber #kcsm onclive.com/view/time-to-n…

When nephrology is consulted to manage volume status but cardiology got there first

What's the current and future of biomarker use in the treatment of renal cell carcinoma? A quick bite read in OncLive.com Toni Choueiri, MD Yüksel Ürün Dana-Farber Lank Center for Genitourinary Oncology #kidney #Cancer #MedX #MedTwitter

Dr. Emre Yekedüz from Dana-Farber very nicely discusses adjuvant options for ccRCC! Stay tuned for more insights by following Dr. Emre Yekedüz X Emre Yekedüz OncLive.com Toni Choueiri, MD Dana-Farber Dana-Farber Lank Center for Genitourinary Oncology Ankara Üniversitesi OncoAlert onclive.com/view/dr-yeked-…

💫Proud of learning from negative trials. “Induction avelumab followed by chemoimmunotherapy and maintenance vs chemo alone as f1st line therapy in cis-ineligible mUC (INDUCOMAIN): a randomized phase II study” is out⚡️#rodriguez-vida Bego PValderrama SOGUG Dana-Farber Lank Center for Genitourinary Oncology Dana-Farber

HE WINS IN MONZA!!! 🇮🇹 IT'S CHARLES LECLERC FOR FERRARI AT THEIR HOME RACE - AGAIN! 🏆👏 STUNNING, SIMPLY STUNNING! #F1 #ItalianGP

🚀 Excited to share that I’ve joined Emory School of Medicine & Winship Cancer Institute of Emory University to launch The Berchuck Lab. Our research is focused on using liquid biopsy to improve outcomes for people living with cancer. We’re hiring for several key roles! Learn more & apply: theberchucklab.org

Excited to share our commentary co-authored w/ Zeynep Irem Ozay, MD in Clinical Cancer Research highlighting the ph2 FUZE trial of Debio 1347 & the Rx landscape of FGFR-altered solid tumors! Thanks to the mentorship of Neeraj Agarwal, MD, FASCO GU Cancer Research Program @HuntsmanCancer 👉tinyurl.com/3ca5b7sw👇 UroToday.com OncoAlert

I had the opportunity to represent #ClinicObiome Gustave Roussy as a partner of the #HumanMicrobiomeAction EU Project. Beyond innovative translational projects, we advocate for the acknowledgement of consensus and requirements in the microbiome field. 🔎 thelancet.com/journals/lanmi…

Don't miss our IMG and general open houses in the next two weeks! Join us and get to know Yale IM Traditional Residency Program ✨ Mark D. Siegel Silvia Vilarinho YaleMedPSTP #MATCH2025